Coagulation

Coagulation laboratory tests

Hypercoagulation panel



Topic Completed: 1 November 2012

Minor changes: 22 September 2020

Copyright: 2002-2021, PathologyOutlines.com, Inc.

PubMed Search: Hypercoagulation panel

Jeremy C. Parsons, M.D.
Page views in 2020: 148
Page views in 2021 to date: 173
Table of Contents
Definition / general
Cite this page: Parsons JC. Hypercoagulation panel. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/coagulationhypercoagulationpanel.html. Accessed October 18th, 2021.
Definition / general
  • Panels are useful to identify all factors predisposing to thrombosis; vary by institution
  • Laboratory must be notified if patient is receiving therapeutic anticoagulants (heparin, warfarin, danaparoid, hirudin, argatroban)
  • Venous thrombosis panel typically includes assays for activated protein C resistance (factor V Leiden), protein C, protein S, antithrombin, prothrombin G20210A mutation assay, antiphospholipid antibodies and homocysteine
  • Less common are assays for plasminogen, dysfibrinogenemia (e.g. reptilase time), heparin cofactor II or platelet hyperaggregability
  • Arterial thrombosis panel may include antiphospholipid antibodies, homocysteine levels, lipoprotein (a) (if arterial thrombosis occurs with coronary artery disease, myocardial infarction or stroke)
  • In special circumstances, arterial thrombosis may be due to thrombotic diatheses tested on the venous thrombosis panel

  • Note: clinicians often confuse Factor V Leiden (to workup thrombosis) with Factor V assay (not the correct test); prevent with use of hypercoagulation panel
Back to top
Image 01 Image 02